Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

0.36USD
31 Jul 2015
Change (% chg)

$-0.01 (-3.54%)
Prev Close
$0.37
Open
$0.37
Day's High
$0.37
Day's Low
$0.34
Volume
147,386
Avg. Vol
90,273
52-wk High
$1.11
52-wk Low
$0.28

ACST.O

Chart for ACST.O

About

Acasti Pharma Inc. is a Canada-based biopharmaceutical company focused on the research, development and commercialization of new krill-oil based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, in particular abnormalities in blood lipids, referred to as dyslipidemia.... (more)

Overall

Beta: 0.68
Market Cap(Mil.): $49.04
Shares Outstanding(Mil.): 106.62
Dividend: --
Yield (%): --

Financials

  ACST.O Industry Sector
P/E (TTM): -- 37.25 40.68
EPS (TTM): -0.04 -- --
ROI: -10.62 16.52 15.78
ROE: -11.75 17.30 16.82
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$15.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$49.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks